Bexacat 15mg tablet for cats, 30 tabs
Bexacat® (bexagliflozin tablets) is an oral SGLT2 inhibitor to manage feline diabetes mellitus. It lowers blood glucose by increasing urinary excretion of glucose through inhibition of sodium-glucose cotransporter 2 (SGLT2), and results in effective glycemic control.
Variants (1)
- Default Title — 98.99 CAD — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
80%